# FDA recall D-0058-2023

> **Viatris Inc** · Class I · drug recall initiated 2022-10-07.

## Product

Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).

## Reason for recall

Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0058-2023
- **Recalling firm:** Viatris Inc
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-10-07
- **Report date:** 2022-11-16
- **Termination date:** 2024-01-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Canonsburg, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0058-2023

## Citation

> AI Analytics. FDA recall D-0058-2023. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0058-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*